Envoy Medical Inc
COCH1.435USD
-0.010-0.69%
Market hours （ET）Quotes delayed by 15 min
USD0.000Pre-market (ET)
30.88MMarket Cap
LossP/E TTM
Envoy Medical Inc
1.435
-0.010-0.69%
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
Operating cash flows (indirect method)
Cash flow from continuing operating activities
33.35%-3.73M
62.53%-4.39M
-355.41%-2.81M
-21.67%-4.91M
-85.62%-5.59M
-392.14%-11.71M
144.35%1.10M
-104.67%-4.03M
-52.30%-3.01M
---2.38M
---2.48M
---1.97M
---1.98M
Net income from continuing operations
20.29%-5.00M
5.39%-4.62M
-504.89%-5.96M
70.20%-3.95M
52.69%-6.27M
57.47%-4.88M
209.93%1.47M
-971.68%-13.25M
-608.34%-13.25M
---11.48M
---1.34M
---1.24M
---1.87M
Operating gains losses
79.41%61.00K
0.00%48.00K
68.97%49.00K
44.83%42.00K
25.93%34.00K
84.62%48.00K
31.82%29.00K
107.14%29.00K
107.69%27.00K
--26.00K
--22.00K
--14.00K
--13.00K
Other non-cash items
-35.90%250.00K
382.75%1.37M
307.54%633.00K
-1962.96%-503.00K
4775.00%390.00K
3957.14%284.00K
-1116.67%-305.00K
-63.51%27.00K
124.24%8.00K
--7.00K
--30.00K
--74.00K
---33.00K
Change in working capital
217.89%1.42M
85.12%-1.01M
-66.27%1.59M
3.33%403.00K
-265.56%-1.20M
-1485.31%-6.79M
836.56%4.71M
186.76%390.00K
597.26%726.00K
--490.00K
---640.00K
--136.00K
---146.00K
-Change in receivables
2912.00%753.00K
-329.93%-589.00K
50.00%-27.00K
137.50%19.00K
213.64%25.00K
-344.64%-137.00K
---54.00K
-78.38%8.00K
52.17%-22.00K
--56.00K
--0.00
--37.00K
---46.00K
-Change in inventory
152.86%74.00K
-376.67%-143.00K
1350.00%203.00K
-1263.64%-300.00K
-600.00%-140.00K
-193.75%-30.00K
109.33%14.00K
58.49%-22.00K
221.74%28.00K
--32.00K
---150.00K
---53.00K
---23.00K
-Change in prepaid expenses
-33.93%-75.00K
-1720.00%-648.00K
188.76%624.00K
159.38%76.00K
-51.35%-56.00K
-46.67%40.00K
-511.30%-703.00K
-293.94%-128.00K
-408.33%-37.00K
--75.00K
---115.00K
--66.00K
--12.00K
-Change in other current liabilities
-18.18%-39.00K
1832.61%797.00K
-694.12%-945.00K
692.06%746.00K
59.26%-33.00K
90.67%-46.00K
-260.61%-119.00K
-190.00%-126.00K
42.14%-81.00K
---493.00K
---33.00K
--140.00K
---140.00K
Cash from non-recurring investing activities
Cash from operating activities
33.35%-3.73M
62.53%-4.39M
-355.41%-2.81M
-21.67%-4.91M
-85.62%-5.59M
-392.14%-11.71M
144.35%1.10M
-104.67%-4.03M
-52.30%-3.01M
---2.38M
---2.48M
---1.97M
---1.98M
Investing cash flow
Net cash from continuing investing activities
--6.00K
----
1766.13%1.16M
3145.45%357.00K
-100.00%0.00
-48.78%21.00K
-18.42%62.00K
-85.14%11.00K
118.52%59.00K
--41.00K
--76.00K
--74.00K
--27.00K
Capital expenditures
--6.00K
----
1766.13%1.16M
3145.45%357.00K
-100.00%0.00
-48.78%21.00K
-18.42%62.00K
-85.14%11.00K
118.52%59.00K
--41.00K
--76.00K
--74.00K
--27.00K
Net cash flow from disposal of fixed assets
--6.00K
----
1766.13%1.16M
3145.45%357.00K
-100.00%0.00
-48.78%21.00K
-18.42%62.00K
-85.14%11.00K
118.52%59.00K
--41.00K
--76.00K
--74.00K
--27.00K
Net cash flow from other investing activities
----
--534.00K
--542.00K
---433.00K
---109.00K
----
----
----
----
----
----
----
----
Cash from non-current investing activities
Net cash flow from investing activities
94.50%-6.00K
2642.86%534.00K
-891.94%-615.00K
-7081.82%-790.00K
-84.75%-109.00K
48.78%-21.00K
18.42%-62.00K
85.14%-11.00K
-118.52%-59.00K
---41.00K
---76.00K
---74.00K
---27.00K
Financing cash flow
Cash flow from continuous financing activities
-44.69%3.55M
651.52%4.91M
-61.23%6.10M
-16.67%2.50M
60.65%6.43M
-144.55%-891.00K
408.93%15.74M
200.00%3.00M
100.00%4.00M
--2.00M
--3.09M
--1.00M
--2.00M
Net cash flow from debt Issuance/repayment
0.00%5.00M
-50.00%5.00M
-25.00%7.50M
-16.67%2.50M
25.00%5.00M
400.00%10.00M
233.33%10.00M
200.00%3.00M
100.00%4.00M
--2.00M
--3.00M
--1.00M
--2.00M
Net cash flow from common stock issuance/repurchase
----
----
--0.00
--0.00
--1.68M
--109.00K
----
----
----
----
----
----
----
Net cash flow from preferred stock issuance/repurchase
----
----
----
----
----
----
--1.00M
----
----
----
----
----
----
Cash dividend payments
--1.21M
--614.00K
--1.83M
----
----
----
----
----
----
----
----
----
----
Proceeds from stock option exercised by employees
----
--63.00K
----
----
----
----
----
----
----
----
----
----
----
Proceeds from issuance of warrants
----
--1.38M
--434.00K
----
----
----
----
----
----
----
----
----
----
Net cash flow from other financing activities
9.34%-233.00K
91.67%-916.00K
----
----
---257.00K
---11.00M
5047.83%4.74M
----
----
--0.00
--92.00K
----
----
Net cash from non-recurrent financing activities
Net cash from financing activities
-44.69%3.55M
651.52%4.91M
-61.23%6.10M
-16.67%2.50M
60.65%6.43M
-144.55%-891.00K
408.93%15.74M
200.00%3.00M
100.00%4.00M
--2.00M
--3.09M
--1.00M
--2.00M
Net cash flow
Beginning cash balance
29.99%5.48M
-73.73%4.42M
2505.97%1.75M
343.90%4.95M
2204.92%4.22M
2660.82%16.84M
-5.63%67.00K
-0.45%1.11M
-83.68%183.00K
--610.00K
--71.00K
--1.12M
--1.12M
Current period cash flow changes
-123.52%-171.00K
108.39%1.06M
-84.03%2.68M
-205.83%-3.20M
-21.91%727.00K
-2856.21%-12.62M
3017.66%16.77M
0.10%-1.05M
46650.00%931.00K
---427.00K
--538.00K
---1.05M
---2.00K
Effect of exchange rate changes
700.00%6.00K
33.33%-2.00K
---1.00K
0.00%-1.00K
-200.00%-1.00K
57.14%-3.00K
----
50.00%-1.00K
-50.00%1.00K
---7.00K
----
---2.00K
--2.00K
Ending cash balance
7.42%5.31M
29.99%5.48M
-73.73%4.42M
2467.65%1.75M
343.90%4.95M
2204.92%4.22M
2665.19%16.84M
-5.56%68.00K
-0.45%1.11M
--183.00K
--609.00K
--72.00K
--1.12M
Free cash flow
33.24%-3.73M
62.60%-4.39M
-482.26%-3.96M
-30.16%-5.26M
-82.05%-5.59M
-384.67%-11.73M
140.60%1.04M
-97.80%-4.04M
-53.19%-3.07M
---2.42M
---2.55M
---2.04M
---2.00M
Currency unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit opinions
--
--
--
--
--
--
--
--
--
--
--
--
--
